The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk
Open Access
Abstract
Objective To determine the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared with surgical aortic valve replacement (SAVR) in a high-risk aortic stenosis (AS) population. Design A cost-utility analysis employing the National Institute of Clinical Excellence (NICE) reference case design for technology appraisals. Setting The perspective of the UK National Health Service. Patients Utility data from a UK high-risk AS population. TAVI and SAVR effectiveness was taken from the PARTNER A randomised controlled trial. Main outcome measures Costs modelled over a 10 year horizon using a Markov model. Incremental cost-effectiveness ratios and cost-effectiveness acceptability curve were calculated with reference to the NICE willingness to pay per quality adjusted life year (QALY) gain threshold. Deterministic and probabilistic sensitivity analyses performed. Results Despite greater procedural costs (£16 500 vs £9,256), TAVI was cost-effective compared with SAVR over the 10 year model horizon (costs £52 593 vs £53 943 and QALYs 2.81 vs 2.75), indicating that TAVI dominated SAVR. This appeared to be due to greater postsurgical costs, related to the length and cost of hospital stay. The results appeared robust to a number of deterministic sensitivity and probabilistic analyses. The cost-effectiveness acceptability curve indicated that at the NICE £20 000 willingness to pay threshold per QALY gained, TAVI had a 64.6% likelihood of being cost-effective, compared with 35.4% for SAVR. Conclusions TAVI is likely to be a cost-effective treatment for high-risk patients with AS compared with the reference standard of SAVR. However, uncertainty surrounding the long-term outcomes for TAVI patients remains; this could have a substantive impact on estimates of cost-effectiveness.Keywords
This publication has 32 references indexed in Scilit:
- Cost-Effectiveness of Transcatheter Aortic Valve Replacement Compared With Surgical Aortic Valve Replacement in High-Risk Patients With Severe Aortic StenosisJACC, 2012
- Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve ReplacementNew England Journal of Medicine, 2012
- Serial Change in Health-Related Quality of Life Over 1 Year After Transcatheter Aortic Valve ImplantationJACC, 2012
- Long-Term Outcomes After Transcatheter Aortic Valve Implantation in High-Risk Patients With Severe Aortic StenosisJACC, 2011
- 2-Year Follow-Up of Patients Undergoing Transcatheter Aortic Valve Implantation Using a Self-Expanding Valve ProsthesisJACC, 2011
- Conventional aortic valve replacement for high-risk aortic stenosis patients not suitable for trans-catheter aortic valve implantation: feasibility and outcome?European Journal of Cardio-Thoracic Surgery, 2011
- Costs of Stroke Using Patient-Level DataStroke, 2009
- Conducting economic evaluations alongside multinational clinical trials: Toward a research consensusAmerican Heart Journal, 2005
- Quality of life and NYHA class 30 years after mechanical aortic valve replacementCardiovascular Surgery, 2003
- Patient preferences for stroke outcomes.Stroke, 1994